**Core Concept**
Drug-induced hallucinations are a well-documented side effect of various medications, particularly those affecting the central nervous system. These hallucinations can manifest as visual, auditory, or even tactile and can significantly impact a patient's quality of life. The underlying mechanism often involves disruption of normal neurotransmitter activity, particularly serotonin and dopamine.

**Why the Correct Answer is Right**
The correct answer is related to the pharmacological properties of certain medications. For instance, anticholinergic medications, such as antihistamines and some antipsychotics, can lead to hallucinations due to their blockade of muscarinic receptors in the brain. On the other hand, drugs that increase dopamine levels, like amphetamines and cocaine, can cause hallucinations by overactivating dopamine receptors in the mesolimbic pathway.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a well-documented cause of drug-induced hallucinations. However, if it were a known cause, the explanation would be similar to the correct option, involving disruption of normal neurotransmitter activity.
* **Option B:** This option is incorrect because it is a known cause of drug-induced hallucinations. For example, antipsychotic medications, such as haloperidol, can cause hallucinations in some patients due to their blockade of dopamine receptors in the mesolimbic pathway.
* **Option C:** This option is incorrect because it is a known cause of drug-induced hallucinations. For instance, certain antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), can cause hallucinations in rare cases, particularly in patients with a history of psychosis.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that drug-induced hallucinations can be a sign of medication toxicity or an underlying psychiatric condition. Therefore, it is essential to carefully evaluate patients with hallucinations and consider the potential role of medications in their development.

**Correct Answer: B. Haloperidol**